Bluestar Genomics closes $70M Series C funding, expands scientific advisory board

Must Read

Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early cancer detection, today announced the company had raised $70 million in new equity funding. Led with the …

Latest News

Ministry verifies damage data in NTT quake affected villages

Semarang, Central Java (ANTARA) - Indonesia's Villages and Development of Disadvantaged Regions Ministry has begun verifying the extent of...

More Articles Like This